Smith & Nephew CFO joins Reckitt Benckiser September 17, 2012 Consumer goods firm Reckitt Benckiser has appointed Adrian Hennah as new chief financial officer. Hennah joins from Smith & Nephew, and will assume the position at the end of December, to replace Liz Doherty, who is stepping down next March. He has held the position of chief financial offer at the medical devices group since [...]
Reckitt Benckiser ditches CFO after culture clash September 17, 2012 CONSUMER goods giant Reckitt Benckiser yesterday ditched its current chief financial officer Liz Doherty in favour of Smith & Nephew’s Adrian Hennah, after it admitted Doherty was not “well matched” to the firm. Doherty, who was appointed in January 2011, will remain working at the company until March 2013. Hennah will join in December 2012, [...]
Reckitt loses fight to block generic drugs February 25, 2013 SHARES in Reckitt Benckiser closed three per cent lower yesterday after US authorities said they will allow rivals to produce generic versions of the firm’s heroin substitute. The consumer health goods company’s pharmaceuticals division makes most of its profit from Suboxone, a treatment containing buprenorphine that helps people addicted to opiates cope with ceasing to [...]
Firms going ex-dividend hit FTSE 100 February 13, 2013 The leading share index fell this morning, ending a three-session rally as it was weighed down by a number of blue chips going ex-dividend. Pharmaceutical giant AstraZeneca led the fallers, shedding more than three per cent as it went ex-dividend. Business software provider Sage and oil giant BP fell 1.63 per cent and 1.44 per [...]
Firms going ex-dividend hit FTSE 100 February 13, 2013 The leading share index fell this morning, ending a three-session rally as it was weighed down by a number of blue chips going ex-dividend. Pharmaceutical giant AstraZeneca led the fallers, shedding more than three per cent as it went ex-dividend. Business software provider Sage and oil giant BP fell 1.63 per cent and 1.44 per [...]
Cough and cold season boosts Reckitt figures February 13, 2013 A HEAVY flu and cold season in the US caused misery for many people but helped Strepsils-maker Reckitt Benckiser yesterday report a healthy lift in fourth quarter sales. Reckitt said sales in Europe and North America grew three per cent after “higher incidences of cold and flu” had boosted demand for products such as Mucinex [...]
Amec weighs on FTSE February 14, 2013 The FTSE 100 edged down this morning as oil engineer Amec weighed heavily on the index. Shares in the engineer lost more than 5.5 per cent in early trading, despite it posting an 11 per cent hike in annual earnings this morning, enabling it to pledge a 20 per cent increase in its dividend. “In [...]
Reckitt secures healthy boost with Schiff deal November 22, 2012 CONSUMER products group Reckitt Benckiser is to acquire Schiff Nutrition for $1.4bn (£878m). The board of Schiff Nutrition, which sells vitamins, nutrition supplements and nutrition bars, has approved the transaction at $42 a share and recommended shareholders agree the deal. The FTSE 100 consumer group will finance the deal using cash and existing credit facilities. [...]
FTSE shrugs off downgrade February 25, 2013 THE blue chip index rose this morning – led by headline mining and banking shares – on signs that the US and Japan would continue loose monetary policy for some time. The FTSE 100 was up 0.7 per cent in early deals, as the market brushed off Moody’s downgrade of the UK’s AAA credit rating, [...]
Market braced for bad news in Inflation Report February 10, 2013 ECONOMISTS have warned that markets should be braced for bad news this week as the Bank of England releases its quarterly update on the UK’s financial outlook. “The upcoming Inflation Report is likely to project that inflation will still be clearly above the two per cent target two years ahead, and perhaps not even back [...]